Cargando…
Recombinant human erythropoietin therapy in critically ill patients
Autores principales: | Georgopoulos, D, Matamis, D, Xirouchaki, N, Routsi, C, Michalopoulos, A, Maggina, A, Dimopoulos, G, Zakynthinos, E, Nakos, G, Thomopoulos, G, Mandragos, K, Vasiliadou, G, Peftoulidou, M, Maniati, A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4098486/ http://dx.doi.org/10.1186/cc3399 |
Ejemplares similares
-
Recombinant human erythropoietin therapy in critically ill patients: a dose-response study [ISRCTN48523317]
por: Georgopoulos, Dimitris, et al.
Publicado: (2005) -
Data on respiratory variables in critically ill patients with acute respiratory failure placed on proportional assist ventilation with load adjustable gain factors (PAV+)
por: Georgopoulos, Dimitris, et al.
Publicado: (2016) -
Science review: Recombinant human erythropoietin in critical illness: a role beyond anemia?
por: Coleman, Thomas, et al.
Publicado: (2004) -
Heart-focused anxiety in critically ill patients' relatives
por: Konstanti, Z, et al.
Publicado: (2014) -
Pupillometry in critically ill patients with COVID-19: a prospective study
por: Vrettou, Charikleia S., et al.
Publicado: (2020)